Lefamulin
Lefamulin is a topic covered in the Johns Hopkins ABX Guide.
To view the entire topic, please log in or purchase a subscription.
Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:
-- The first section of this topic is shown below --
INDICATIONS
FDA
FDA
- Treatment of community-acquired pneumonia caused by susceptible organisms.
- Streptococcus pneumoniae, methicillin-susceptible Staphylococcus aureus, Haemophilus influenzae,Legionella pneumophila, Mycoplasma pneumoniae, and Chlamydophila pneumoniae.
NON-FDA APPROVED USES
NON-FDA APPROVED USES
- In vitro activity has been demonstrated against methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant Enterococcus faecium, multidrug-resistant Neisseria gonorrhoeae, and Mycoplasma genitalium.
-- To view the remaining sections of this topic, please log in or purchase a subscription --
INDICATIONS
FDA
FDA
- Treatment of community-acquired pneumonia caused by susceptible organisms.
- Streptococcus pneumoniae, methicillin-susceptible Staphylococcus aureus, Haemophilus influenzae,Legionella pneumophila, Mycoplasma pneumoniae, and Chlamydophila pneumoniae.
NON-FDA APPROVED USES
NON-FDA APPROVED USES
- In vitro activity has been demonstrated against methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant Enterococcus faecium, multidrug-resistant Neisseria gonorrhoeae, and Mycoplasma genitalium.
There's more to see -- the rest of this topic is available only to subscribers.
© 2000–2022 Unbound Medicine, Inc. All rights reserved